# Effects of the Eefooton on eGFR and QoL in Chronic Kidney Disease Patients.

> **NCT04940117** · NA · COMPLETED · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 100 (actual)

## Conditions studied

- Chronic Kidney Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Eefooton oral solution

## Key facts

- **NCT ID:** NCT04940117
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-10-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04940117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04940117, "Effects of the Eefooton on eGFR and QoL in Chronic Kidney Disease Patients.". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT04940117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*